The primary endpoint at week 72 was the percentage change in weight from baseline
Researchers discovered an antioxidant, glutathione, that cancer cells appear to be "addicted to" as fuel, opening new pathways for investigation and a potential drug that can restrict the way tumors use this nutrient
Evidence, Safety, and the Regulatory Landscape GLP-1 microdosing is biologically plausible, but its safety and effectiveness have not been validated in randomized clinical trials
Learn more about weight management and diabetes here:
Holst highlights the challenges patients face with GLP-1 therapy, particularly regarding long-term use
all skin safety data derives from clinical trials, and suspected reactions should be reported via the MHRA Yellow Card scheme